Gefitinib: A Review of its Use in the Management of Advanced Non-Small-Cell Lung Cancer

Author： James E. Frampton   Stephanie E. Easthope  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.21, 2004-01, pp. : 2475-2492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

By Sanford Mark   Scott Lesley J.  

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2303-2328

Adis International

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer

By Baldwin Claudine M.   Perry Caroline M.  

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2279-2302

Adis International

Access to resources Recommend Favorite

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E.   Easthope Stephanie E.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status

By Chang Gee-Chen   Chen Kun-Chieh   Yang Tsung-Ying   Yin Ming-Chang   Lin Ching-Pei   Kuo Benjamin Ing-Tiau   Hsu Jeng-Yuan  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 73-77

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 75-92

Adis International

Access to resources Recommend Favorite